Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-244 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
filingDate |
2013-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6097bea03ade2cc9c6a7a2fa9c7018a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2a15a4bece417196b3915cf976f7259 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36b9c2db6d1a66cd8eb7a51b484e0610 |
publicationDate |
2014-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2746293-A1 |
titleOfInvention |
Anti-IL21 antibodies for use in the treatment of cardiovascular diseases |
abstract |
The present invention relates to treatment of cardiovascular diseases and arthero-sclerosis. In particular, the present invention relates to use of therapeutic antibodies. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115353566-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115353566-B |
priorityDate |
2012-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |